Therapeutic Monitoring of Infliximab and Adalimumab
Condition: Inflammatory Bowel Diseases Interventions: Drug: Infliximab; Drug: Adalimumab Sponsor: IRCCS Burlo Garofolo Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Application of N-of-1 Rheumatoid Arthritis
Condition: Arthritis, Rheumatoid Interventions: Drug: Adalimumab; Drug: Sarilumab; Drug: Upadacitinib Sponsor: Tufts Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials